Literature DB >> 850090

Clindamycin and Carbenicillin in treatment of patients with intraabdominal and female genital tract infections.

R M Swenson, B Lorber.   

Abstract

Clindamycin alone and with an aminoglycoside or carbenicillin alone and with an aminoglycoside were used in therapy for 173 patients with intraabdominal or genital tract infections. Excellent or good results were obtained in 115 of 131 patients treated with clindamycin and 33 of 42 patients treated with carbenicillin. Few serious side effects were observed in patients who received either drug. The data indicate that clindamycin is an effective drug in these conditions and suggest that carbenicillin may be equally effective.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850090     DOI: 10.1093/infdis/135.supplement.s40

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.

Authors:  G R Monif; P R Clark; J J Shuster; H Baer
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

Review 2.  Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.

Authors:  J S Solomkin; J L Meakins; M D Allo; E P Dellinger; R L Simmons
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

Review 3.  Obstetric infections.

Authors:  H A Oster
Journal:  West J Med       Date:  1981-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.